Deltex Medical Group plc announced that group sales for statutory reporting purposes are expected to be circa £6.5 million for 2014 compared to £7.2 million reported in 2013. The company expects the shortfall in sales against market forecasts to result in losses being approximately £1.2 million higher than market expectations.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.115 GBX | 0.00% | 0.00% | -20.69% |
08/05 | TRADING UPDATES: ECO hails vaccine results; Plant Health sales down | AN |
02/04 | EARNINGS: AdvancedAdvT hails "good progress" after Capita deal | AN |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.69% | 2.77M | |
-15.37% | 2.82B | |
+2.69% | 188M | |
-17.50% | 80.71M | |
+10.14% | 50.66M |
- Stock Market
- Equities
- DEMG Stock
- News Deltex Medical Group plc
- Deltex Medical Group plc Provides Earnings Guidance for 2014